Loading organizations...
Loading organizations...
Key people at Oncode Oncology Bridge Fund.
Oncode Oncology Bridge Fund was founded by Emil Pot (Co-Founder and CEO) and René Kuijten (Vice Chairman Supervisory Board, Initiator, Founder).
Oncode Oncology Bridge Fund was founded by Emil Pot (Co-Founder and CEO) and René Kuijten (Vice Chairman Supervisory Board, Initiator, Founder).
Key people at Oncode Oncology Bridge Fund.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 4, 2025 | Laigo Bio | $13.4M Seed | Mariette van der Velden, Thierry Laugel | Lola Buono, Neill Moray Mackenzie, Phil Masterson, Eurazeo, Emil Pot, ROM Utrecht Region |
| Apr 24, 2024 | Flindr Therapeutics | $21.4M Series A | Christina Takke | BOM, Curie Capital, Tine Bekaert, Johnson & Johnson Innovation, Chris De Jonghe, Cedric Van Nevel, Swanbridge Capital |
| Laigo Bio | $6.0M Laigo Bio Seed Extension Mar 2026 | Kurma Partners, Biovance Capital, Joao Incio, MD PhD | Angelini Ventures, ArgoBio, Cancer Research Horizons, Curie Capital, Eurazeo, ROM Utrecht Region |
